Video Clips

Quoted moments from Alaska public meetings, hearings, and press conferences.

0:16

Ashley Carrick

isn't it already illegal for a noncitizen simply to register to vote?

Alaska Legislature: MISC-20260722-1300 · Jul 22, 2026

0:24

Patty Murray

research at the Pittsburgh VA to predict stroke risk was put on hold. Enrollment into clinical trials for advanced cancer was delayed, and a clinical trial in Florida on preventing dementia and heart disease was canceled.

Senate Veterans' Affairs (Sullivan): Hearings to examine advancing the mission, focusing on evaluating the future of VA research. · Jul 22, 2026

0:33

Patty Murray

it is my intention to rip Trump's budget up and write a new one.

Senate Veterans' Affairs (Sullivan): Hearings to examine advancing the mission, focusing on evaluating the future of VA research. · Jul 22, 2026

0:03

Steve Daines

Absolutely. Let's go a little left to right here. Yeah. Yes. Thank you.

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

0:26

Steve Daines

This bill is very simple. It requires all conditions to be directly related to a project.

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

0:06

Mike Lee

Yes. You know my answer, Senator. Yes. Okay, nobody said heck yes or more than that, but good. I'm glad to hear yes.

Senate Energy and Natural Resources (Murkowski): An oversight hearing to examine the Federal Regulatory Commission. · Jul 22, 2026

0:54

Tammy Baldwin

This bipartisan amendment would restore a pilot program for uninsured patients to access insulin for $35 a month and a resource center to help patients afford and access affordable insulin. Both of these policies were in the original text of the Insulin Act, but unfortunately are not in the manager's amendment before us today.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:53

Tammy Baldwin

As drafted, the legislation could require many dairy products, including milk, cheese, and yogurt to carry an FDA warning label unless the FDA chooses to exempt them through its regulatory authority. This places tremendous weight on agency discretion rather than providing a clear direction in statute. I oppose this bill today because I think we have more work to do to get this right.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026

0:31

Susan Collins

I support this amendment and pleased to be the principal co-sponsor. The original bill that we reintroduced in this Congress had this provision in it in an attempt to move the bill along. We agreed to take it out and decide it at the committee level. But I think it's important that we not leave this population, the most vulnerable population, behind.

Senate Health, Education, Labor, and Pensions (Murkowski): Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care. · Jul 22, 2026